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Abstract 
Review on MAPK4, with data on DNA, on the 
protein encoded, and where the gene is implicated. 
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Identity 
HGNC (Hugo): MAPK4 
Location: 18q21.1 
Other names: ERK4, PRKM4, pP63mapk 
Local order: The MAPK4 gene is located between 
the genes SKA1 (C18orf24) and MRO on 
chromosome 18 
DNA/RNA 
Description 
The MAPK4 gene spans 171.7 kb on the long arm 
of chromosome 18 and is transcribed in the 
centromere-to-telomere orientation.  
The gene is composed of 6 exons with the 
translation initiation codon located in exon 2. The 
first two exons are separated by a long intron of 
102.8 kb. 
Transcription 
The MAPK4 transcribed mRNA has 4,736 bp. No 
splice variants have been reported. 
Pseudogene 
None. 
Protein 
Description 
Extracellular signal-regulated kinase 4 (ERK4) is 
an atypical member of the mitogen-activated 
protein (MAP) kinase family of serine/threonine 
kinases. The human ERK4 protein is made of 587 
amino acids and contains a typical kinase domain 
located at the N-terminal extremity. Another region 
with homology to the MAP kinase ERK3 (C34 
domain) has been identified after the kinase 
domain. The function of the C34 domain is 
unknown. 
Figure 1. Genomic organization of the MAPK4 gene on chromosome 18. 
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Figure 2. Schematic representation of the ERK4 protein structure. Kinase, catalytic kinase domain; C34 conserved region in 
ERK3 and ERK4; SEG, activation loop motif containing the regulatory phosphorylation residue Ser186. 
 
Expression 
MAPK4 mRNA is expressed to the highest level in 
the brain. Other sites of expression include the 
heart, lung, kidney, intestine, pancreas, parathyroid 
gland, prostate, thymus, ovary, eye and ear. 
Localisation 
ERK4 localizes to the cytoplasm and nucleus of a 
variety of cultured cells. 
Function 
Little is known about the regulation and functions 
of ERK4. The only known substrate of ERK4 is the 
protein kinase MAPKAPK5 (MK5). 
Homology 
ERK4 display 73% amino acid identity with ERK3 
in the kinase domain. ERK4 and ERK3 define a 
distinct subfamily of MAP kinases. 
Mutations 
The R114C/H mutation has been reported in several 
types of cancer (colorectal adenocarcinoma, diffuse 
glioma, non-small cell lung cancer, cutaneous 
melanoma, stomach adenocarcinoma, uterine 
carcinosarcoma). The functional impact of this 
mutation on the expression or activity of ERK4 is 
not known. 
Implicated in 
Cancer 
Analysis of copy number alterations (CNAs) from 
TCGA datasets show that MAPK4 gene is deleted 
in several adenocarcinomas, includingprostate, 
esophageal, stomach and lung adenocarcinomas. 
Also, a chromosomal subregion containing the 
MAPK4 gene is deleted with high frequency (23%) 
in pancreatic adenocarcinoma. On the other hand, 
MAPK4 is amplified with low frequency in 
neuroendocrine prostate cancer, diffuse large B-cell 
lymphoma and sarcomas.  
Interrogation of the Oncomine database reveals that 
expression of MAPK4 mRNA is downregulated in 
breast and prostate cancer.  
Consistent with CNA analysis, MAPK4 mRNA is 
upregulated in diffuse large B-cell lymphoma. 
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